Recombinant multi-species ATG9B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATG9B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene functions in the regulation of autophagy, a lysosomal degradation pathway. This gene also functions as an antisense transcript in the posttranscriptional regulation of the endothelial nitric oxide synthase 3 gene, which has 3' overlap with this gene on the opposite strand. Mutations in this gene and disruption of the autophagy process have been associated with multiple cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]
The Alternative Names of target: APG9-like 2,APG9L2,ATG9B,Apg912,Apg9l2,Apgdc2,Atg9b,Autophagy-related protein 9B,Gm574,NOS3AS,Nitric oxide synthase 3-overlapping antisense gene protein (Protein sONE),Nos3as,RGD1560887,SONE,eONE,sONE
Go
to ATG9B products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0379-Ag-1/ GM-Tg-hg-IP0379-Ag-2 | Human ATG9B protein | Human |
GM-Tg-rg-IP0379-Ag-1/ GM-Tg-rg-IP0379-Ag-2 | Rat ATG9B protein | Rat |
GM-Tg-mg-IP0379-Ag-1/ GM-Tg-mg-IP0379-Ag-2 | Mouse ATG9B protein | Mouse |
GM-Tg-cynog-IP0379-Ag-1/ GM-Tg-cynog-IP0379-Ag-2 | Cynomolgus/Rhesus macaque ATG9B protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0379-Ag-1/ GM-Tg-felg-IP0379-Ag-2 | Feline ATG9B protein | Feline |
GM-Tg-cang-IP0379-Ag-1/ GM-Tg-cang-IP0379-Ag-2 | Canine ATG9B protein | Canine |
GM-Tg-bovg-IP0379-Ag-1/ GM-Tg-bovg-IP0379-Ag-2 | Bovine ATG9B protein | Bovine |
GM-Tg-equg-IP0379-Ag-1/ GM-Tg-equg-IP0379-Ag-2 | Equine ATG9B protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP0379-Ag-1/ GM-Tg-hg-IP0379-Ag-2;
GM-Tg-rg-IP0379-Ag-1/ GM-Tg-rg-IP0379-Ag-2;
GM-Tg-mg-IP0379-Ag-1/ GM-Tg-mg-IP0379-Ag-2; GM-Tg-cynog-IP0379-Ag-1/ GM-Tg-cynog-IP0379-Ag-2; GM-Tg-felg-IP0379-Ag-1/ GM-Tg-felg-IP0379-Ag-2; GM-Tg-cang-IP0379-Ag-1/ GM-Tg-cang-IP0379-Ag-2; GM-Tg-bovg-IP0379-Ag-1/ GM-Tg-bovg-IP0379-Ag-2; GM-Tg-equg-IP0379-Ag-1/ GM-Tg-equg-IP0379-Ag-2 |
Products Name | ATG9B protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | ATG9B |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATG9B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.